Motivated by genetic association studies of pleiotropy, we propose here a Bayesian latent variable approach to jointly study multiple outcomes or phenotypes. The proposed method models both continuous and binary phenotypes, and it accounts for serial and familial correlations when longitudinal and pedigree data have been collected. We present a Bayesian estimation method for the model parameters, and we develop a novel MCMC algorithm that builds upon hierarchical centering and parameter expansion techniques to efficiently sample the posterior distribution. We discuss phenotype and model selection in the Bayesian setting, and we study the performance of two selection strategies based on Bayes factors and spike-and-slab priors. We evaluate the proposed method via extensive simulations and demonstrate its utility with an application to a genome-wide association study of various complication phenotypes related to type 1 diabetes.
Introduction
Pleiotropy occurs when a single genetic factor influences multiple continuous or binary phenotypes, and it is present in many genetic studies of complex human traits such as diabetes, hypertension and cardiovascular diseases. In genetic studies of complications or secondary manifestations of a disease, it is often believed that there are common genetic risk factors for the different phenotypes. In other cases, the primary and often conceptual phenotype (e.g. disease severity) may not be directly measured or be characterized by one single phenotype, and a set of surrogate response variables must instead be used. These response variables (phenotypes or outcomes) are mutually correlated as they measure the underlying trait from different perspectives. In order to take into account all information and to increase statistical efficiency, it is desirable to model these outcomes jointly.
An added characteristic of many emerging large-scale genetic studies is the collection of repeated measures over time in correlated individuals (family data). For example, the ongoing T2D-GENES (Type 2 Diabetes Genetic Exploration by Nextgeneration sequencing in multi-Ethnic Samples) consortium study includes longitudinal measures of various T2D-revelant phenotypes (e.g. blood glucose levels and blood pressures) and other covariates (e.g. sex, body mass index and medication history), and these measures are collected for 2,500 individuals from 85 Mexican-American families. Similarly, the DCCT (Diabetes Control and Complications Trial) study includes longitudinal measures of various type 1 diabetes (T1D) complications, which we analyze in this paper.
The longitudinal family studies combine the features of longitudinal studies in independent individuals and studies using single-time-point phenotype measures in families, providing more information about the genetic and environmental factors associated with the traits of interest than cross-sectional studies (Burton et al., 2005) .
However, joint modeling of multiple phenotypes using longitudinal family data involves non-trivial statistical and computational challenges because of the complex correlations that exist between different phenotypes (the phenotypical correlation), between repeated measures from the same phenotype (the serial correlation) and between individuals within the same family (the familial correlation).
Robust and powerful methods for the study of pleiotropy are under-developed in the literature due to data complexities that include a) the phenotypes of interest can be continuous, discrete or both, b) the joint effect of covariates on the multiple phenotypes is difficult to specify, and c) the familial, serial and other correlations are often present in the data as discussed above. There are a number of approaches proposed for cross-sectional data. For instance, Xu et al. (2003) extended the standard linear combination test to incorporate data-driven weighting factors, Weller et al. (1996) applied the principal component analysis to the multiple traits of interest to obtain independent canonical variables and then conducted univariate quantitative trait locus (QTL) analyses, and Lange and Whittaker (2001) developed a QTL-mapping method based on generalized estimating equations.
Here we propose to use the latent variable (LV) methodology to jointly study multiple correlated phenotypes in the presence of serial and familial correlations.
The formulation of a latent variable model (LVM) relies on postulating the effect of a random variable that is not observed by the researchers but is assumed to exert an important influence on the set of observed variables (also known as the manifest variables) and thus induces correlations among them (Bartholomew et al., 2011) . In the context of pleiotropy studies, the manifest variables are the multiple observed phenotypes, which jointly inform the latent variable that represents the underlying conceptual disease status or severity.
The LV methodology has been widely used in many scientific fields including economics, psychology and social sciences, and it is becoming increasingly attractive for genetic studies. For example, O'Hara et al. (2010) proposed a LV approach for the analysis of multivariate quantitative trait loci, Tayo et al. (2008) applied a factor analysis (a sub-type of LVM) to find latent common genetic components of obesity traits, and Nock et al. (2009) used the factor analysis for a metabolic syndrome study.
Initial applications of LVM focused on reducing the number of manifest variables to a smaller number of latent outcomes. Sammel and Ryan (1996) and Sammel and Ryan (1997) extended the LVM to allow covariates to have effects on both the manifest and latent variables. Roy and Lin (2000) discussed a LV approach for longitudinal data with continuous outcomes.
The proposed LVM consists of two parts. The first part models the relationship between the manifest variables and the LV to characterize the within-subject correlation among the different outcomes. The second part uses a linear mixed effect model to investigate the effect of a genetic marker and other covariates on the LV, accounting for the serial and familial correlations. Direct effects of covariates on the manifest variables are also allowed in the first part of model. The paper makes a number of original contributions. The proposed LV method generalizes the work of Roy and Lin (2000) to longitudinal family data with binary and continuous responses. The Bayesian formulation can be desirable in practice as it offers a principled way to incorporate prior information, often available in genetic studies, and to perform finite sample likelihood-based inference. However, the Bayesian model raises important computational challenges because the sampling algorithm required to study the posterior is inefficient when it is applied in its standard form. We introduce a novel algorithm that relies on the hierarchical centering and parameter expansion techniques (Gelfand, 1995; Liu and Wu, 1999; Meng and van Dyk, 1999) to improve computational efficiency.
The rest of the paper is organized as follows. Section 2 introduces the details of the LVM and discusses the consequences of naïvely ignoring the family structure in the data. Section 3 presents a Bayesian estimation for the model parameters and a novel MCMC algorithm designed to sample the posterior distribution efficiently.
Section 4 discusses phenotype selection and model selection in the Bayesian setting.
Section 5 shows results from extensive simulation studies, and Section 6 applies the proposed method to a genetic study of T1D complications. Section 7 concludes with recommendations and further discussions.
2 Latent Variable Model for Longitudinal Family data.
The Statistical Model
Let Y cit = (y cit1 , . . . , y citJ ) be the J × 1 vector of outcomes/phenotypes/manifest variables measured at the t th time on the i th individual from the c th family/cluster for c = 1, 2, . . . , C, i = 1, 2, . . . , N c , t = 1, 2, . . . , T , where C denotes the total number of families, N c is the number of individuals within the c th family, and T is the total number of repeated measurements. Among the J outcomes, Y In the first part of the LVM, a continuous phenotype y c is linked to the latent trait U via a linear mixed model 
, and e citj and b cij are mutually independent for c = 1, . . . , C, i = 1, . . . , N c , t = 1, . . . , T and j = 1, . . . , J.
If a phenotype is binary, a generalized linear mixed model is assumed,
with a probit link,
We choose a probit link instead of a logit link to gain computational efficiency. Specifically, we take advantage of the well-known representation of the probit model based on a normally distributed LV. If y the element of α corresponding to the genetic marker is found to be significant. We assume a c ∈ R q 1 ×1 are the family-specific random effects and Z cit is the corresponding vector of covariates. Similarly, d ci ∈ R q 2 ×1 represents the subject-specific random effects with Q cit its associated covariate vector. We assume that a c
and all random effects are independent of the cit .
Model Identification Restrictions
The following modification of equation (2.1)
where K is an arbitrary nonzero number, suggests that, without any restriction on λ or the variance of U cit , an infinite number of equivalent models can be created. A similar phenomenon appears in the binary phenotype case. In order to avoid unidentifiability, we assume that the variance of U cit is equal to 1 and that λ j is non-negative. Because we allow covariate effects in both parts of the LVM, we assume that the two sets of covariates are disjoint and equation (2.4) does not contain the intercept.
Effects of Ignoring Familial Correlation
Individuals from the same family are genetically related resulting in correlation between their latent disease status. In practice, to reduce the analytic complexity and computation burden, one may choose to assume sample independence and apply existing methods (e.g. Roy and Lin (2000) ). However, ignoring the family structure will cause incorrect inference for the model parameters. To see this clearly, we assume a simplified case where the phenotypes of interest are all continuous and there are no repeated measures. The two parts of LVM are reduced to
where c = 1, . . . , C, i = 1, . . . , N c and j = 1, . . . , J, with independent error terms e cij ∼ N (0, σ 2 j ) and ci ∼ N (0, 1), λ j > 0 and a c ∼ N (0, Σ A ). The variance of the j th response for individual i from family c can be decomposed in terms of the model parameters as:
Suppose we ignore the familial correlation in the data and propose the following model
where h = 1, . . . , N is the individual's index and N is the total sample size. In this case, the variance of the j th response for individual h is decomposed as
By equating (2.6) and (2.7), we find that λ
j and thus it is easy to see that
Therefore, ignoring familial correlation can lead to significant underestimation of α, the effect of a genetic marker on the LV of interest. However, the omission of existing familial correlation leads to overestimation of λ, the effect of the LV on the phenotypes of interest in the first part of the LVM, as demonstrated in the simulation studies of Section 5.2 below. This is consistent with what's reported in the statistical genetics literature (e.g. Thornton and McPeek (2010) ).
In the longitudinal setting, as seen from equation (2.4), ignoring the familial cor-relation will also result in biased estimation of λ and α, as well as the serial correlation Σ D . Simulation results reported in Section 5 support these conclusions. However, particular to the longitudinal setting, if covariates Z are not present, the error caused by ignoring the familial correlation can be absorbed into the serial correlation and thus only Σ D will be incorrectly estimated. Nevertheless, there is still some loss of efficiency in the estimation of λ and α in this case.
Parameter Estimation via Bayesian Method
Traditional solutions for LVM, including the popular software such as LISREL (Jöreskog and Sörbom, 1996) and MPLUS (Muthen and Asparouhov, 2011) , rely on frequentist methods. The development of modern computational algorithms, in particular
Markov chain Monte Carlo (MCMC), enables us to use LVM for dependent data within the Bayesian paradigm. The Bayesian approach also offers a principled approach to produce finite sample likelihood-based inference and to incorporate any available prior information which, in a genetic analysis setup, can be considerable.
Bayesian Model Setup
The data in our model contain the observed continuous or binary outcomes Y, the direct fixed-effect covariates W , the indirect fixed-effect covariates X, and the random-effect covariates Z and Q. The vector of parameters of interest is Θ =
) . Therefore, the posterior distribution for the model parameters is
The complexity of the sampling model requires the use of MCMC algorithms for statistical inference. Unfortunately, the commonly used priors in probit and linear mixed effects models along with a run-of-the-mill sampling scheme lead to a torpidly mixing chain. In the next section, we discuss the prior specifications and the algorithmic modifications that we have implemented to improve the MCMC efficiency.
MCMC sampling
We follow the data augmentation (DA) principle of Tanner and Wong (1987) and sample alternatively from the posterior distribution given the complete data and from the LV's distribution given the observed data and the parameter values. We first discuss the sampling scheme for the relatively simple case when all the phenotypes are continuous and we then extend the algorithm to binary phenotypes.
Continuous Traits
When all the phenotypes are continuous and the conditional conjugate priors are defined for the model parameters, a standard Gibbs (SG) sampler can be used for MCMC sampling from the posterior distribution. However, due to high dependence between the components of the Markov chain corresponding to the parameter vector Θ and the missing and latent data vector Ω, we observe a very slow mixing of the chain. Improvement can be obtained by using hierarchical centering (HC) (Gelfand, 1995) . The HC technique moves the parameters up the hierarchy via model reformulation. Specifically, in (2.1) we move β 0j 's up the model hierarchy to be the mean of the random effect b so that the new random effect is b * cij = β 0j + b cij . Another technique devised to overcome the slow convergence problem of DA algorithms is parameter expansion (PX) (Meng and van Dyk, 1999; Liu and Wu, 1999) . The idea behind PX is to introduce auxiliary parameters in the model and average over all their possible values in order to produce inference for the original model of interest. As demonstrated by Meng and van Dyk (1999) and Liu and Wu (1999) , the benefits of this apparently circuitous strategy can be highly significant, because the larger parameter space allows the Markov chain to move more freely and breaks the dependence between its components.
In our implementations, we have observed a strong coupling between the updates of the random effect b cij and its variance τ 2 j , and between the factor loading λ j and the latent factor U for all 1 ≤ j ≤ J. For instance, an update of τ 2 j close to zero likely yields a small update of b cij and vice versa. Thus, we introduce auxiliary parameters ξ j and ψ and define the following PX with hierarchical centering model (PX-HC)
To relate the original parameters to the expanded parameters, the following transformations are used
The conjugate priors used for the auxiliary parameters involved in the PX scheme lead to a Gibbs sampler in which each conditional distribution is available in closed form and induce the folded-t (the absolute value of t distribution) prior distributions for the parameters τ and λ. More precisely, since Var(b * cij ) = η 2 j in our PX-HC model and Var(b cij ) = τ 2 j in the original model, we have τ j = |ξ j |η j . When the conditional conjugate normal and inverse-Gamma prior are applied to ξ j and η 2 j , respectively, the resulting prior for τ j is the folded-t distribution. Similarly, since λ j = λ * j ψ, a half normal prior assigned to λ * j and inverse-Gamma prior to ψ 2 will result in a folded-t prior for λ j . Other authors have discussed the suitability of folded-t priors in mixed effects and factor analysis models. For instance, Gelman (2006) noted the added flexibility and improved behaviour when random effects are small, and Ghosh and Dunson (2009) suggested the use of t or folded-t priors for the factor loadings in a factor analysis setting.
We consider independent and conjugate priors for the expanded model param-
. For example, we use normal priors for the fixed-effect coefficients. Thus,
For the scale parameters, we specify conditional conjugate priors,
a ) with V a = q 1 + 1 and S a = 10 * I q1 ;
For the auxiliary parameters we have introduced, the priors are
where v 1 and v 2 are the hyperparameters representing the degrees of freedom (df) of the induced folded-t priors for λ j and τ 2 j , respectively. For the purpose of phenotype selection, which will be discussed in detail in Section 4.1, we specify a spike-and-slab prior for λ * j
with the hyperparameter π j ∼ Beta(a, b). Notice that the induced prior for λ in the original inference model is also a spike-and-slab prior with the spike at zero and the slab distribution equal to a folded-t distribution with v 1 df.
After defining the conditional conjugate priors for the expanded model, we now can apply the Gibbs sampling to obtain the posterior samples. Details of sampling are described in the Appendix, and the key steps at a given iteration k − 1 are:
Step 1:
Step 2: Draw Ω
General Traits
Suppose that the phenotypes of interest includes both continuous and binary traits.
Without loss of generality, we assume that the first J 1 phenotypes are continuous and the remaining ones are binary. In order to address concerns involving the MCMC mixing similar to those in the continuous response case, we define the model
and the prior distributions are the same as in the continuous case.
A specific issue encountered here is that some of the conditional distributions required in the Gibbs sampler are not available in closed form. One possible solution is to employ the DA scheme proposed by Albert and Chib (1993) that uses the underlying continuous variable y b citj (discussed in Section 2.1) as an auxiliary variable, so that all the conditional posterior densities in the expanded model can be directly sampled from. However, even in the model defined by (3.4)−(3.6) we have noticed strong posterior dependence between y b citj and some of the model parameters which triggered a sluggish mixing of the chain. We apply an additional layer of the PX scheme by introducing a working parameter γ j and a one-to-one mapping y b * citj = γ j y b citj . We use the marginal DA scheme 3 of van Dyk and Meng (2001) , leaving the prior distributions and the parameterization of the model unchanged. We call this algorithm the doubly parameter-expanded with hierarchical centering and denote it as PX 2 −HC. Below we summarize the kth iteration in the Gibbs sampling algorithm, and we provide a complete description in the Appendix.
Step 1: Draw
Step 2: For j = J 1 + 1, ..., J, the order of updating (β
j , and ξ
The updates of the remaining parameters for the continuous responses and for the second part of the LVM are the same as those for the case with only continuous responses (see Section 3.2.1 and the Appendix).
Step 3: 
Model and Variable Selection 4.1 Selection of Relevant Phenotypes
In medical research, it is of interest to determine if a phenotype under the study is truly relevant to the latent disease status. In the LVM setting, this is equivalent to testing if the coefficient or factor loading λ j for the j th phenotype ((2.1) for continuous phenotype and (2.2) for binary phenotype) is statistically significant or not.
The sign restriction on the factor loadings, λ j s ≥ 0 as discussed in Section 2.2, implies that the highest posterior density interval (HpdI) will seldom include zero and is thus anti-conservative as a selection criterion. To assess the significance of the factor loadings, we apply the Bayesian model selection method using the spike-andslab priors (Mitchell and Beauchamp, 1988; George and McCulloch, 1993; Chipman, 1996; Xu et al., 2011) . Specifically, we use the spike-and-slab prior (3.3) for each λ * j . The point mass at zero shrinks small values of the factor loading towards zero, while the values of a and b reflect the prior belief in λ j = 0 (see Xu et al., 2011 , for a similar discussion on the use of spike-and-slab priors to alleviate the winner's curse in genetic association studies). When there is no prior information, we recommend a = 1 and b = 1 which correspond to π j ∼ Unif(0, 1). For those phenotypes that are a priori considered to be unrelated to the latent disease variable, we can set a = 0.25 and b = 1, thus favouring a priori small values for the corresponding λ j s.
The determination of the relevance of the j th phenotype is based on the posterior probability of positive loading, P r(λ j > 0|Y ). The sampling algorithm discussed in the Appendix introduces the latent mixture indicator ω j = 1 {λ j >0} , so that P r(λ j > 0|Y ) can be approximated by the MCMC sample frequency of {ω j = 1}. Given a pre-specified threshold φ, we assume that any loading with P r(λ j > 0|Y ) ≥ φ should be included in the model. The value for φ depends on the practical problem. If the number of manifest variables is large, the φ value can be chosen to control the overall average Bayesian false discovery rate (FDR) (Morris et al., 2008) . The performance of selecting the correct phenotypes is shown in the simulation Section 5.3.1 below.
Model Selection Using Bayes Factor
Bayes factors are central to the Bayesian model selection and comparison. The Bayes factor for comparing model M 0 and M 1 is defined as:
. Assuming equal model priors for M 0 and M 1 , the posterior odds of the two models equals to the Bayes factor. A calibration of the Bayes factor is given by Kass and Raftery (1995) where log BF > 1 supports M 1 and log BF < 0 supports M 0 .
The calculation of P (Y |M k ) in our setting is challenging as it involves high dimensional integration. We follow the procedure of Lee and Song (2002) and use the parametric arithmetic mean path (PAMP) implementation of the path sampling (see also Dutta and Ghosh, 2012) to compute the Bayes factor. Specifically, we assume an unnormalized density function f θ such that f θ 0 and f θ 1 are the sampling densities for models M 0 and M 1 , respectively. The two models are connected in the parametric space Θ via a path P = {θ g = gθ 0 + (1 − g)θ 1 : g ∈ [0, 1]}, where each θ g ∈ P corresponds to a model M g for which the sampling density function is f (θ g ). The
Bayes factor can then be calculated using the identity
where E Ω,Θ denotes the expectation with respect to the density p(Ω, Θ|Y, g), and
To compute the integral in equation (4.1), we choose S fixed values {g 1 , . . . , g S } such that g (0) = 0 < g (1) < g (2) < ... < g (S) < 1 = g (S+1) and then estimate log BF by We are concerned here with assessing the factor loadings, λ j s, as discussed in Section 4.1. Suppose that we are interested in testing λ j 0 = 0. Let M g be the model with factor loadings equal to (λ 1 , . . . ,
The first part of the LVM for M g that links the phenotype Y j s and the LV U is 
where σ 2 j 0 = 1 for the binary phenotypes. The logBF can then be obtained via Equations (4.2) and (4.3) with U calculated using the above equation. Dutta and Ghosh (2012) showed that the calculation of Bayes factor is valid when
The condition holds when the prior distribution for λ has the first two moments finite, which is true for our relatively diffuse folded-t prior with ten df. To explore the sensitivity of the Bayes factor estimation to the changes of df in the folded-t prior, we also consider df ∈ {3, 10, 40, 90}.
Another concern is the tuning of the grid sizes when using equation (4.2) as the approximation of log BF . Dutta and Ghosh (2012) suggested a grid size no bigger than 0.01, corresponding to 100 grid numbers in [0, 1]. However, due to conflict between the prior and sampling distributions, when λ is large,
has large spikes when g is close to zero, but it stabilizes gradually as g increases.
Thus we suggest to use uneven grid size scheme so that smaller grid sizes are chosen for g near zero. For example, in our simulations below we set the grid number to be 15 for g ∈ [0, 0.1] and also 15 for g ∈ [0.9, 1] and observed good results.
Selection of Pleiotropic Genetic Marker via Bayes Factors
An important inferential focus in genetic pleiotropy study is the selection of genetic marker(s) with pleiotropic effect. Particularly, we are interested in testing the effect of a genetic marker on the LV. Suppose that the fixed-effect covariates X in the second part of the LVM has two components where X 1 is the set of clinical covariates and X 2 is the genotype of the marker of interest. The two competing LV models are then
The two models can be linked up by the parameter g ∈ [0, 1] as:
Let L g be the complete-data likelihood for model M g , then
Again log BF can be obtained using (4.2) and (4.3) with U calculated as above.
Simulation study
We have identified three practically relevant issues related to the model's performance that we wanted to study via simulations: 1) the performance of our proposed method in parameter estimation, 2) the effect of ignoring the family structure, and 3) the performance of the proposed variable selection methods introduced in Section 4. for the covariate (serial correlation) follow an AR(1) model with autocorrelation being 0.3. We also assume that each phenotype is measured over time five times. Unless specified otherwise, the default choice is π j ∼ Beta(1, 1) in the spike-and-slab prior given in (3.3), assuming no prior information on the relationship between phenotype j and the LV. In all the simulations, we run the MCMC algorithm for 25,000 iterations, discarding the first 5,000 samples as burn-in.
Parameter estimation for general traits.
To evaluate the performance of the proposed parameter estimation, we assume here that five phenotypes are of interest among which y 1 , y 2 and y 3 are continuous, and y 4 and y 5 are binary (Tables 1 and 2 ). We use a total of 100 replications to study the variation of estimates and also compare the performance of our PX 2 −HC algorithm with those of the standard algorithms. Figure 1 shows that, compared to AC-PX-HC, the standard PX algorithm with the DA scheme of Albert and Chib (1993) , the proposed PX 2 −HC algorithm drastically reduces the autocorrelations between the chains's realizations which implies an increase in Monte Carlo efficiency. The improvement is also evident in Figure   2 , when comparing the standard Gibbs (left column) with the proposed PX 2 −HC scheme (right plots). In the Appendix, we provide the corresponding trace plots to illustrate the improved mixing of the PX 2 −HC chain. given the discrepancy between the information provided by the two types of data. Figure 3 shows that around 95% of the HpdIs for the factor loadings λs cover the true values. However, this remains to be validated theoretically for more general setting as results seem to suggest a matching prior type of result.
Effect of Ignoring Family Structure
In this simulation, we only consider the three continuous phenotypes y 1 , y 2 and y 3 and generate data with familial and serial correlations as above in Section 5.1. We compare parameter estimates obtained using the proposed method to model the familial correlation with the estimates obtained using the method of Roy and Lin (2000) assuming samples are independent of each other.
The simulation results in Table 3 show that failure to account for the familial correlation present in the data will not only yield incorrect conclusion of the serial correlations between phenotypes Σ D , but also cause over-estimation of the factor loading λ j , which quantifies the strength of the relationship between phenotype y j and the latent variable U , and under-estimation of α 1 and α 2 , which respectively, represents the effect of the clinical covariate and genetic marker on U .
Model and Variable Selection

Selection of Relevant Phenotypes via Spike-and-Slab Priors
To assess the performance of phenotype selection using the spike-and-slab prior (3.3)
as described in Section 4.1, we consider here four continuous phenotypes y c with factor loading λ j s being set to (0.5, 0.05, 0.02, 0) and three binary phenotypes y b with λ j s being (0.2, 0.01, 0). We chose these values so that the strength of the association between a phenotype and the LV U ranges from strong (λ j = 0.5) to no association (λ j = 0). We set π ∼ Beta(0.25, 1) which favours a priori the null (λ j = 0). After the calculation of the posterior frequency of ω j = 1 for each phenotype in the 100
replicates, a threshold of φ = 50% is used on the posterior probability P r(λ j > 0|Y ).
Simulation results show that the type I error of this selection procedure is about 5% in that, for the phenotype not associated with the latent disease status (λ j = 0), around 5% of the replications have P r(λ j > 0|Y ) ≥ 0.5. For phenotypes moderately or strongly associated the latent variable (λ j = 0.05 or higher), we have 100% power of making the correct decision. However, power is reduced for weakly associated phenotypes as expected. Specifically for the case consider here, power is 71% for the phenotype with λ j = 0.02 and 16% for λ j = 0.01.
Selection of Relevant Phenotypes via Bayes Factors
We have also examined the performance of phenotype selection via Bayes factors for the comparison of model M 1 (assuming λ > 0) and model M 0 (assuming λ = 0) using the same simulation model as in the previous section. The logBF s for the λ's are calculated using the folded-t prior with df = 10 as described in Section 4.2.1. Table 4 show that when phenotype y j is truly associated with the latent variable with λ j ≥ 0.05, the average estimated log(BF ) > 5.9. This and combined with the SD shown in the table suggest that, for such cases, the Bayes factor criterion chooses the correct alternative model 100% of the times. When phenotype y j is truly not associated with the LV (λ j = 0), the Bayes factor criterion correctly favors the null model with the average estimated log(BF ) < −2.4. However, the Bayes factor criterion has little ability in identifying weakly associated phenotypes (λ j ≤ 0.02), which is inferior to the spike-and-slab approach in the previous section. We have also explored the use of other folded-t priors with df ranging from 3, 10, 40 to 90. We find that all the prior settings give us the same conclusion on the model selection.
Results in
Selection of Pleiotropic Genetic Marker or Other Covariates
For this purpose, we assume that there are five indirect fixed-effect covariates X 1 , . . . , X 5 in the second part of the LVM that models the effect of the genetic marker and other covariates on the latent variable. We assume that X 3 is the genotype of the marker of interest and the remaining ones are standardized continuous variables. Coefficients (α 1 , α 2 , α 3 , α 4 , α 5 ) quantify the effects of the five covariates which are set to be (1.0, −0.5, 0.2, 0, 0). We also assume that there are two continuous standardized direct fixed-effect covariates W 1 and W 2 in the first part of the LVM with effects (β 1 = 0.5 and β 2 = 0.3) on all the phenotypes. Table 5 shows the estimated log(BF ) for comparing the null model assuming α j = 0 with the alternative of association. The prior distribution for α in (2.4) is α ∼ N (0, I 5 ). Results show that the proposed Bayes factor criterion has the ability to detect the association between the genetic marker and the latent variable, therefore pleiotropy, with the average estimated log(BF ) = 6.3 and SD = 2.39. The Bayes factor variable selection criterion also has good result for the two associated covariates X 1 and X 2 for which the average log(BF ) estimate is, respectively, 337.5 and 6.3, as well as for the two covariates X 4 and X 5 with zero effect, for which the estimated log(BF ) is consistently less than −1.9 with SD = 0.42.
6 Application to a genetic study of type 1 diabetes (T1D) complications.
Here we demonstrate the practical utility of the proposed LVM method by investigating the blood pressure data from a genome-wide association study (GAWS) of various T1D complications (Paterson et al., 2010) . The study sample consists of n = 1300 individuals with T1D from the Diabetes Control and Complications Trial (DCCT).
Various phenotypes thought be to related to T1D complication severity, including glycosylated hemoglobin (HbA1c) and diastolic (DBP) and systolic blood pressure (SBP), were collected from each subject over the course of the DCCT. Additional covariates such as sex and body mass index (BMI) were also collected, and individuals were from two different cohorts and subjected to two treatment types (conventional vs. intensive). Over 800K SNPs were genotyped by the Illumina 1M bead chip assay for these individuals.
Because T1D is a complex disease with various complication measures (the observed phenotypes), it is of great interest to quantify the conceptual latent complication status, as well as to understand the influencing factors (both genetic markers and clinical covariates). In addition, it is valuable to determine if the various observed phenotypes are truly associated with the latent variable. However, due to lack of suitable statistical methodology, previous analyses have been limited to the standard uni-phenotype approach, analyzing one phenotype at a time. For example, Ye et al.
(2010) recently performed GAWS, separately, for DBP and SBP, and they identified rs7842868 on chromosome 8 as a SNP significantly associated with DBP.
Our goal here is to formally perform a multi-phenotype analysis, jointly analyzing DBP and SBP using the proposed Bayesian LVM methodology. This approach allows us not only to determine if rs7842868 is associated with the latent conceptual T1D complication variable, but also to test if DBP and SBP are truly related to the LV.
It is also of practical interest to study whether there are other phenotypes such as hyperglycemia (HPG) influence the latent complication severity variable.
In our application, we investigate three phenotypes Y among which two are continuous (DBP and SBP) and one is binary (HPG = 1 for hyperglycemia if and = 0 for normal glycemia), all are longitudinal. Hyperglycemia at a given time point is defined if the corresponding HbA1c is greater or equal to 8. Among the available covariates, based on suggestions from clinicians, covariates W that have direct effects on the phenotypes include BMI, and covariates X that have direct effects on the LV include sex, cohort and treatment. Among the 10 longitudinal measurements available, there are significant amount of missing data after the 7 th measure (due to staggered entry) while there are little missing data before the 5 th measure. Therefore, we only use the first five measurements. We treat the remaining missing data as
Missing at Random (MAR), and we replace the missing data with the means of all the other measurements. In this dataset, there is only one person in each family therefore there is no familial correlation, but the proposed methodology remains suitable by assuming the cluster size being 1.
We first consider rs7842868, a SNP found by Ye et al. (2010) to be associated with DBP. In this case X 1 is the genotype of rs7842868. Results in Table 6 show that DBP and SBP are clearly associated with the latent variable with estimated logBF over 100, while HPG is not. We also applied the spike-and-slab prior method for phenotype selection as discussed in Sections 4.1 and 5.3.1, the poster probability P r(λ j > 0|Y ) is 1 for DBP and SBP and 0.235 for HPG. Thus all model selection criteria consistently suggest that both DBP and SBP are significantly related to the latent variable but not HPG. Results also show that SNP rs7842868 is significantly associated with the latent variable with estimated logBF over 10 and the 95% HpdI not covering 0. The sign of the effect suggest that the minor allele of the SNP is protective in that it decreases the latent complication severity score. The combined evidence from both parts of the LVM show that rs7842868 has pleiotropic effect on the two blood pressures. Sex and cohort are also found to be significantly associated with the latent variable but not treatment.
We then investigate rs1358030, a SNP found by Paterson et al. (2010) to be associated with HbA1c. In this case, X 1 is the genotype of rs1358030. Based on results in Table 6 , there is no evidence that rs1358030 is significantly associated with the latent variable. Our application here considers the binary hyperglycaemia (HPG)
as the third phenotype of interest instead of the continuous HbA1c variable. Besides clinical consideration, this choice also allows us to evaluate the proposed method for general traits as described in Section 3.2.2
To further evaluate the proposed method, we simulate genotypes for two NULL SNPs that are not associated with the phenotypes of interest. One SNP has MAF equal to 0.25, the MAF of rs7842868), and the other one has MAF equal to 0.35, the MAF of rs1358030. As expected, no significant associations are detected.
Conclusion and Disucssion
We propose here a Bayesian latent variable approach to joint model multiple out- An important issue for pleiotropy studies is the assessment of importance of each variable. We have adopted two Bayesian techniques that are shown to be effective in variable selection. We found that both Bayes factor and spike-and-slab prior perform well with the latter slightly more efficient in terms of detecting weak signals.
Our proof-of-principle application to a genetic study of type 1 diabetes complications demonstrates the utility of the method in a real data setting. So far, genetic association studies of various T1D complication-related measures have been limited to studying one phenotype at a time. The proposed method jointly analyzes two continuous and one binary phenotypes of interest, and it provides evidence for the association between the phenotypes and the latent severity of T1D complication, the association between the latent variable and genetic markers of interest, and the effect of other covariates on the phenotypes and the latent variable.
The computational load in the current implementation of the proposed method makes it impractical to perform a genome-wide search for pleiotropic genetic variants.
The recent advances in parallel computing can partially alleviate this constraint.
Alternatively, a two-stage approach can be used in which a simple and less stringent selection procedure is first used to select a moderate number of candidate variants for further investigation using the proposed method. The uncertainty inherited from the first-stage selection, however, must be accounted for in the models used in the second stage.
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Latent variable U has direct effect λ (also called factor loading) on each of the Y s Table 6 : Application results. SNP rs7842868 was previously identified to be associated with diastolic blood pressure (DBP) and SNP rs1358030 was previously identified to be associated with HbA1c. Phenotypes of interest are DBP and systolic blood pressure (SBP), two continuous outcomes, and hyperglycemia (HPG, defined as HbA1c greater or equal to 8), a binary outcome. All phenotypes are thought to be related to type 1 diabetes complication severity. The coefficient λs assess the association between the phenotypes and the latent T1D complication status, and αs evaluate the association between the latent variable and the genetic marker and the other covariates of interest. See Section 6 and Figure 1: Autocorrelation functions (ACF) for the AC-PX-HC (dashed line) scheme and the proposed P X 2 -HC sampling scheme (solid line), averaged over 100 simulation replicates. The autocorrelation is based on the posteriors of the factor loadings λ 4 (left panel) and λ 5 (right panel) for the two binary phenotypes as simulated in Section 5.1 and described in Table 1 . 
